- Home
- LIVN vs DBD Comparison
LIVN vs DBD Comparison
Compare LIVN & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIVN
- DBD
- Stock Information
- Founded
- LIVN 1987
- DBD 1859
- Country
- LIVN United Kingdom
- DBD United States
- Employees
- LIVN N/A
- DBD N/A
- Industry
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DBD EDP Services
- Sector
- LIVN Health Care
- DBD Technology
- Exchange
- LIVN Nasdaq
- DBD Nasdaq
- Market Cap
- LIVN 2.1B
- DBD 2.2B
- IPO Year
- LIVN 1993
- DBD N/A
- Fundamental
- Price
- LIVN $52.21
- DBD $57.74
- Analyst Decision
- LIVN Strong Buy
- DBD Strong Buy
- Analyst Count
- LIVN 7
- DBD 2
- Target Price
- LIVN $59.71
- DBD $75.00
- AVG Volume (30 Days)
- LIVN 544.9K
- DBD 171.2K
- Earning Date
- LIVN 10-29-2025
- DBD 11-06-2025
- Dividend Yield
- LIVN N/A
- DBD N/A
- EPS Growth
- LIVN N/A
- DBD N/A
- EPS
- LIVN N/A
- DBD N/A
- Revenue
- LIVN $1,309,329,000.00
- DBD $3,672,300,000.00
- Revenue This Year
- LIVN $10.10
- DBD $3.09
- Revenue Next Year
- LIVN $7.75
- DBD $2.74
- P/E Ratio
- LIVN N/A
- DBD N/A
- Revenue Growth
- LIVN 8.23
- DBD N/A
- 52 Week Low
- LIVN $32.48
- DBD $34.88
- 52 Week High
- LIVN $58.91
- DBD $63.46
- Technical
- Relative Strength Index (RSI)
- LIVN 44.91
- DBD 46.46
- Support Level
- LIVN $49.29
- DBD $55.66
- Resistance Level
- LIVN $54.25
- DBD $59.16
- Average True Range (ATR)
- LIVN 1.41
- DBD 1.39
- MACD
- LIVN -0.36
- DBD 0.10
- Stochastic Oscillator
- LIVN 43.37
- DBD 45.76
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
About DBD Diebold Nixdorf Incorporated Common stock
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.